These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1314177

  • 1. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
    Araujo FG, Lin T, Remington JS.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
    Araujo FG, Remington JS.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1672-3. PubMed ID: 1656872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
    Araujo FG, Prokocimer P, Remington JS.
    J Infect Dis; 1992 Apr; 165(4):788. PubMed ID: 1532409
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF, Hammouda E, Tawfik A, Al-Omar OM, Abu El-Asrar AM.
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
    Moshkani SK, Dalimi A.
    Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
    [Abstract] [Full Text] [Related]

  • 11. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG, Shepard RM, Remington JS.
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG, Slifer T, Remington JS.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD, Silva NM, Ferro EA, Sousa RA, Firminot ML, Bernardes ES, Roque-Barreira MC, Pena JD.
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA, Fernandes MD, Machado AS, Reis-Cunha JL, Bartholomeu DC, Almeida Vitor RW.
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S, Bryskier A, Moutot M, Derouin F.
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.